 | • レポートコード：MRC2305A152 • 出版社/出版日：Transparency Market Research / 2023年3月14日 • レポート形態：英文、PDF、235ページ • 納品方法：Eメール（納期：要問合せ） • 産業分類：医療 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本市場調査資料によると、世界の経カテーテル心臓弁置換及び修復術市場規模が、2023年の34億ドルから2031年には80億ドルまで年平均9.7%成長すると見込まれています。本資料は経カテーテル心臓弁置換及び修復術の世界市場について広く調査し、序論、仮定、調査方法、エグゼクティブサマリー、市場概要、新型コロナウイルス感染症分析、処置別（大動脈弁置換術、僧帽弁修復術、肺動脈弁置換術）分析、疾患別（大動脈弁狭窄症、僧帽弁閉鎖不全症、大動脈弁逆流、僧帽弁狭窄症、その他）分析、エンドユーザー別（病院、心臓カテーテル研究所、外来手術センター）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、競争状況、主要ポイントなどをまとめています。また、本資料には、Abbott Laboratories、Edwards Lifesciences Corporation、Medtronic plc、Boston Scientific Corporation、JenaValve Technology, Inc.、Meril Life Sciences、Sahajanand Medical Technologies Limited、MicroPort Scientific Corporation、Venus Medtech (Hangzhou) Inc.、Suzhou Jiecheng Medical Technology Co. Ltd.などの企業情報が含まれています。 ・序論 ・仮定 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・新型コロナウイルス感染症分析 ・世界の経カテーテル心臓弁置換及び修復術市場規模：処置別 - 経カテーテル大動脈弁置換術の市場規模 - 経カテーテル僧帽弁修復術の市場規模 - 経カテーテル肺動脈弁置換術の市場規模 ・世界の経カテーテル心臓弁置換及び修復術市場規模：疾患別 - 大動脈弁狭窄症の市場規模 - 僧帽弁閉鎖不全症の市場規模 - 大動脈弁逆流の市場規模 - 僧帽弁狭窄症の市場規模 - その他疾患の市場規模 ・世界の経カテーテル心臓弁置換及び修復術市場規模：エンドユーザー別 - 病院における市場規模 - 心臓カテーテル研究所における市場規模 - 外来手術センターにおける市場規模 ・世界の経カテーテル心臓弁置換及び修復術市場規模：地域別 - 北米の経カテーテル心臓弁置換及び修復術市場規模 - 中南米の経カテーテル心臓弁置換及び修復術市場規模 - ヨーロッパの経カテーテル心臓弁置換及び修復術市場規模 - アジア太平洋の経カテーテル心臓弁置換及び修復術市場規模 - 中東・アフリカの経カテーテル心臓弁置換及び修復術市場規模 ・競争状況 ・企業情報 ・主要ポイント |
Transcatheter Heart Valve Replacement & Repair Market – Scope of Report
TMR’s report on the global transcatheter heart valve replacement & repair market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global transcatheter heart valve replacement & repair market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global transcatheter heart valve replacement & repair market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the transcatheter heart valve replacement & repair market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global transcatheter heart valve replacement & repair market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global transcatheter heart valve replacement & repair market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global transcatheter heart valve replacement & repair market.
The report delves into the competitive landscape of the global transcatheter heart valve replacement & repair market. Key players operating in the global transcatheter heart valve replacement & repair market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global transcatheter heart valve replacement & repair market profiled in this report.
Key Questions Answered in Global Transcatheter Heart Valve Replacement & Repair Market Report
• What is the sales/revenue generated by transcatheter heart valve replacement & repair across all regions during the forecast period?
• What are the opportunities in the global transcatheter heart valve replacement & repair market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?
Transcatheter Heart Valve Replacement & Repair Market – Research Objectives and Research Approach
The comprehensive report on the global transcatheter heart valve replacement & repair market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global transcatheter heart valve replacement & repair market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global transcatheter heart valve replacement & repair market.
レポート目次1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Transcatheter Heart Valve Replacement & Repair Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Technological Advancements
5.2. Disease Prevalence & Incidence Rate Globally With Key Countries
5.3. Key Industry Events
5.4. COVID-19 Impact Analysis
6. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by Procedure
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Procedure, 2017–2031
6.3.1. Transcatheter Aortic Valve Replacement (TAVR)
6.3.2. Transcatheter Mitral Valve Repair (TMVR)
6.3.3. Transcatheter Pulmonary Valve Replacement (TPVR)
6.4. Market Attractiveness Analysis, by Procedure
7. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by Indication
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Indication, 2017–2031
7.3.1. Aortic Stenosis
7.3.2. Mitral Regurgitation
7.3.3. Aortic Regurgitation
7.3.4. Mitral Stenosis
7.3.5. Tricuspid Regurgitation
7.4. Market Attractiveness Analysis, by Indication
8. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Cardiac Catheterization Laboratories
8.3.3. Ambulatory Surgical Centers
8.4. Market Attractiveness Analysis, by End-user
9. Global Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2017–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Procedure, 2017–2031
10.2.1. Transcatheter Aortic Valve Replacement (TAVR)
10.2.2. Transcatheter Mitral Valve Repair (TMVR)
10.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
10.3. Market Value Forecast, by Indication, 2017–2031
10.3.1. Aortic Stenosis
10.3.2. Mitral Regurgitation
10.3.3. Aortic Regurgitation
10.3.4. Mitral Stenosis
10.3.5. Tricuspid Regurgitation
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Cardiac Catheterization Laboratories
10.4.3. Ambulatory Surgical Centers
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Procedure
10.6.2. By Indication
10.6.3. By End-user
10.6.4. By Country
11. Europe Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Procedure, 2017–2031
11.2.1. Transcatheter Aortic Valve Replacement (TAVR)
11.2.2. Transcatheter Mitral Valve Repair (TMVR)
11.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
11.3. Market Value Forecast, by Indication, 2017–2031
11.3.1. Aortic Stenosis
11.3.2. Mitral Regurgitation
11.3.3. Aortic Regurgitation
11.3.4. Mitral Stenosis
11.3.5. Tricuspid Regurgitation
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Cardiac Catheterization Laboratories
11.4.3. Ambulatory Surgical Centers
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Procedure
11.6.2. By Indication
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Procedure, 2017–2031
12.2.1. Transcatheter Aortic Valve Replacement (TAVR)
12.2.2. Transcatheter Mitral Valve Repair (TMVR)
12.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
12.3. Market Value Forecast, by Indication, 2017–2031
12.3.1. Aortic Stenosis
12.3.2. Mitral Regurgitation
12.3.3. Aortic Regurgitation
12.3.4. Mitral Stenosis
12.3.5. Tricuspid Regurgitation
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Cardiac Catheterization Laboratories
12.4.3. Ambulatory Surgical Centers
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Procedure
12.6.2. By Indication
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Procedure, 2017–2031
13.2.1. Transcatheter Aortic Valve Replacement (TAVR)
13.2.2. Transcatheter Mitral Valve Repair (TMVR)
13.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
13.3. Market Value Forecast, by Indication, 2017–2031
13.3.1. Aortic Stenosis
13.3.2. Mitral Regurgitation
13.3.3. Aortic Regurgitation
13.3.4. Mitral Stenosis
13.3.5. Tricuspid Regurgitation
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Cardiac Catheterization Laboratories
13.4.3. Ambulatory Surgical Centers
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Procedure
13.6.2. By Indication
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Transcatheter Heart Valve Replacement & Repair Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Procedure, 2017–2031
14.2.1. Transcatheter Aortic Valve Replacement (TAVR)
14.2.2. Transcatheter Mitral Valve Repair (TMVR)
14.2.3. Transcatheter Pulmonary Valve Replacement (TPVR)
14.3. Market Value Forecast, by Indication, 2017–2031
14.3.1. Aortic Stenosis
14.3.2. Mitral Regurgitation
14.3.3. Aortic Regurgitation
14.3.4. Mitral Stenosis
14.3.5. Tricuspid Regurgitation
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Cardiac Catheterization Laboratories
14.4.3. Ambulatory Surgical Centers
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Procedure
14.6.2. By Indication
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player – Competitive Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Abbott Laboratories
15.3.1.1. Company Overview
15.3.1.2. Procedure Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Edwards Lifesciences Corporation
15.3.2.1. Company Overview
15.3.2.2. Procedure Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Boston Scientific Corporation
15.3.3.1. Company Overview
15.3.3.2. Procedure Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. B. Braun Melsungen AG
15.3.4.1. Company Overview
15.3.4.2. Procedure Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Medtronic plc
15.3.5.1. Company Overview
15.3.5.2. Procedure Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Meril Life Sciences
15.3.6.1. Company Overview
15.3.6.2. Procedure Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Sahajanand Medical Technologies Limited
15.3.7.1. Company Overview
15.3.7.2. Procedure Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. MicroPort Scientific Corporation
15.3.8.1. Company Overview
15.3.8.2. Procedure Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Venus Medtech (Hangzhou) Inc.
15.3.9.1. Company Overview
15.3.9.2. Procedure Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Suzhou Jiecheng Medical Technology Co. Ltd.
15.3.10.1. Company Overview
15.3.10.2. Procedure Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Peijia Medical Limited
15.3.11.1. Company Overview
15.3.11.2. Procedure Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Blue Sail Medical Co., Ltd.
15.3.12.1. Company Overview
15.3.12.2. Procedure Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview